The Cancer Vaccine Center is Developing
Safe, Effective Vaccines for Patients With Cancer
Welcome to the Cancer Vaccine Center (CVC). We are developing safe and effective vaccines for patients with cancer. The CVC maintains an integrated program of scientific discovery, preclinical vaccine development and clinical investigation. As part of Dana-Farber Cancer Institute, the CVC is affiliated with Harvard Medical School and Dana-Farber/Harvard Cancer Center.
CVC Feature
A new vaccine-and-antibody treatment shows effectiveness in advanced melanoma and ovarian cancer patients. In a new study, CVC researchers and their colleagues show that giving periodic infusions of "monoclonal" antibodies to patients who have received a particular cancer vaccine unleashes a strong immune response to tumors, with less-harsh side effects.
